Two Types of Author Profiles: Auto-Generated or Opt-In

Author profiles are extremely useful vehicles for increasing the visibility and discoverability of your published work. Although it is more popular in the business world, many researchers now have LinkedIn profiles that they may use to push out information about their research and publications to their professional community.

However, there are also some more scholarly options that are worthy of investigation, as they may increase your chances of having your work discovered online by other researchers who may be interested in building on your research or in engaging with you in scholarly collaboration.

There are two types of author profiles: 1) auto-generated ones and 2) “opt-in” ones.

1) Auto-generated Author Profiles:

In the case of auto-generated Author Profiles, when the author publishes a new work, the database producer will automatically add the new citation record to the profile, without further author involvement needed. All profiles are available for viewing by searchers of the database and often include some research impact metrics. (Note: It is a good idea to periodically check your Scopus and Web of Science database profiles for accuracy as errors may negatively-impact the research impact metrics being reported on your Author Profile.)


  • Synapse (MSK Authored Works)
    Synapse is a database of citations to MSK-authored works (e.g., journal articles, meeting abstracts, book chapters, etc.) that includes some traditional research metrics and alternative metrics (embedded/sourced from a vendor called Dimensions).

  • Scopus Author Profiles
    Scopus Author Profiles include metrics (e.g. H-Index) that are generated via citation analysis of the contents of the Scopus database, which includes “Times Cited” data.

  • Web of Science Author Profiles
    Similar to Scopus Author Profiles, however, the new version of Web of Science will include additional details that may speak to an individual author’s research impact, for example, Author Position information (First or Last author, etc.).

2) Opt-In Author Profiles:

In the case of opt-in Author Profiles, the author can choose to register for an account with a particular service and create a profile. It is the author’s responsibility to add citations to the profile and to update it whenever they publish new works. The author can also decide to make the profile public or private (i.e., they are in control over who/what gets viewed).


    ORCID (Open Researcher and Contributor ID) is an independent, not-for-profit, non-proprietary Author Profile resources that does not provide metrics, a reporting interface, or a collaboration portal, but they enable other organizations to provide these services. Many journal publishers and database providers have started integrating ORCID links/info into their products. For example, the ORCID symbol is often included as a hyperlink (on HTML and PDF of articles) that leads to that author’s ORCID profile, allowing readers of this paper to immediately discover other works by that author.

  • Publons (via Web of Science)
    The source of research impact metrics data in this resource is its sister product, Web of Science. A unique feature of Publons is that it allows authors to get verified credit for their participation in the peer-review process.

  • Google Scholar
    Google Scholar’s greatest advantage is that it is free and not behind a paywall, as are Scopus and Web of Science.


Since your ORCID profile is “opt-in”, it is not automatically updated with your new works. Recognizing that keeping opt-in Author Profiles up-to-date can be time-consuming, the MSK Library has created an app that makes it easy to push items from your “auto-generated” Synapse profile to your “opt-in” ORCID profile. You can use the ORCID@MSK app to connect your Synapse profile to your ORCID profile. Since Synapse is automatically updated, you can periodically login to ORCID@MSK and pass on the new items added to Synapse to your ORCID profile so that it also stays up-to-date.

Be sure to check out the MSK Library‘s training class on Measuring Research Impact or to Ask Us if you have any questions about Author Profiles.

New MSK LibGuide on COVID-19

Over the last year, the impact of the COVID-19 pandemic has been felt by everyone in all walks of life, across the planet. It is not surprising, therefore, that the amount of COVID-19 related information available, both scholarly and not, has continued to grow exponentially.

With over 5,000 trials registered in, over 120,000 openly-available journals article in PubMed Central (PMC), over 110,000 records in PubMed, over 2,000 COVID-19 related systematic reviews or meta-analyses, and even 296 publications by MSK authors (as of 3/11/2021), efforts to organize this information and make it more discoverable couldn’t be more welcome.

Thanks to the savvy information evaluation and organization skills of MSK Library Research Informationist, Kendra Godwin, the MSK community and the public at large can now take advantage of the Library’s new COVID-19 LibGuide to discover the plethora of COVID-19 resources and tools available online.

The MSK Library COVID-19 LibGuide includes resources arranged across nine tabs/sections:

  • Home
  • Local Resources
  • Resource Collections, News, and Trackers
  • Literature
  • Mental Health and Workplace Safety
  • Equity, Ethics, and Communication
  • Guiding Clinical and Cancer Care
  • Research, Data, and Visualizations 
  • Information for Cancer Patients and Caretakers

Included resources come from sources ranging from the Centers for Disease Control and Prevention (CDC), to scholarly publishers, professional organizations, public and private institutions, etc., that are both national and international. This finding aid will hopefully help fulfill a variety of information needs, both work-related and personal.

For more information about the COVID-19 LibGuide, please feel free to Ask Us at the MSK Library.

PRISMA-S Extension for Reporting Literature Searches

First introduced in 2009, the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement provides guidance to authors, journal editors, and readers about which informational elements should ideally be reported on and in what detail in a systematic review (SR) publication.

With the increase in systematic review publications over the last decade came more variance and variety within the SR/evidence synthesis study design, prompting the need for even more specialized guidance. Responding to this need, various special interest PRISMA groups worked to develop “extensions” to the PRISMA reporting guidelines, their number now reaching ten.

From the Equator Network:

PRISMA-Equity: Welch V, Petticrew M, Tugwell P, Moher D, O’Neill J, Waters E, White H; PRISMA-Equity Bellagio group. PRISMA-Equity 2012 Extension: Reporting Guidelines for Systematic Reviews with a Focus on Health Equity. PLoS Med. 2012;9(10):e1001333. PMID: 23222917

PRISMA-Abstracts: Beller EM, Glasziou PP, Altman DG, Hopewell S, Bastian H, Chalmers I, Gøtzsche PC, Lasserson T, Tovey D; PRISMA for Abstracts Group. PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts. PLoS Med. 2013;10(4):e1001419. PMID: 23585737

PRISMA-P: Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. PMID: 25554246

PRISMA-IPD: Stewart LA, Clarke M, Rovers M, Riley RD, Simmonds M, Stewart G, Tierney JF; PRISMA-IPD Development Group. Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement. JAMA. 2015;313(16):1657-1665. PMID: 25919529

PRISMA extension for network meta-analyses: Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JP, Straus S, Thorlund K, Jansen JP, Mulrow C, Catalá-López F, Gøtzsche PC, Dickersin K, Boutron I, Altman DG, Moher D. The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations. Ann Intern Med. 2015;162(11):777-784. PMID: 26030634

PRISMA-harms: Zorzela L, Loke YK, Ioannidis JP, Golder S, Santaguida P, Altman DG, Moher D, Vohra S; PRISMA harms group. PRISMA harms checklist: improving harms reporting in systematic reviews. BMJ. 2016;352:i157. PMID: 26830668

PRISMA-CI: Guise JM, Butler ME, Chang C, Viswanathan M, Pigott T, Tugwell P; Complex Interventions Workgroup. AHRQ Series on Complex Intervention Systematic Reviews – Paper 6: PRISMA-CI Extension Statement & Checklist. J Clin Epidemiol. 2017. PMID: 28720516

PRISMA-DTA: McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM; and the PRISMA-DTA Group. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement. JAMA. 2018;319(4):388-396. PMID: 29362800

PRISMA-ScR: Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, Macdonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tunçalp Ö, Straus SE. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018. PMID: 30178033

The latest PRISMA extension to be published in 2021 is the PRISMA-S extension which provides detailed guidance related to the preferred reporting of SR literature searches.

Rethlefsen ML, Kirtley S, Waffenschmidt S, Ayala AP, Moher D, Page MJ, Koffel JB; PRISMA-S Group. PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews. Syst Rev. 2021 Jan 26;10(1):39. doi: 10.1186/s13643-020-01542-z. PMID: 33499930; PMCID: PMC7839230.

To learn more about best practices regarding the literature search required – and its reporting – for a systematic review, be sure to check out the MSK Library’s Systematic Review Service LibGuide and/or consider attending an upcoming training class.